Reviewed and fact-checked by Alessandro Grenci, Superintendent Pharmacist. Read our editorial policy to see how we create informative, accurate content.
Mounjaro’s Golden Dose: Why You Shouldn’t Use It
What is Mounjaro?
Mounjaro is a prescription weight-loss injection containing tirzepatide, a dual-action medicine that targets GLP-1 and GIP receptors to reduce appetite, slow gastric emptying and improve blood sugar regulation. It is licensed for adults with obesity or overweight and related health risks, particularly where diet and exercise alone have not achieved sufficient weight loss. Clinical studies show average weight reductions of up to 20% with continued, correct use, making adherence to dosing instructions central to both safety and results. Understanding how each pen is designed to be used is an important part of deciding whether treatment is right for you.
What is the golden 5th dose?
The golden 5th dose refers to the small amount of liquid left in a Mounjaro KwikPen after the four licensed weekly doses have been administered. This excess volume is included by the manufacturer to ensure accurate delivery of each full dose, not to provide an extra injection. It is not measured, not standardised and not intended for use, which is why official guidance instructs patients to discard the pen after four doses.
Why is it dangerous to use?
Using the golden 5th dose is unsafe because the amount of medicine cannot be reliably measured, increasing the risk of under or overdosing. An unregulated dose may raise the likelihood of side effects such as nausea, vomiting, dehydration and low blood sugar, particularly as doses increase during treatment. The pen mechanism is not designed to deliver a fifth accurate injection, which also introduces a risk of injection error or contamination.
What is considered misuse of Mounjaro?
- Using the golden 5th dose: Injecting the leftover medication exposes you to an unmeasured and unapproved amount of tirzepatide.
- Splitting doses: Dividing a weekly dose into smaller injections alters how the drug is absorbed and reduces treatment reliability.
- Spacing doses irregularly: Extending the gap between doses can reduce effectiveness and increase side effects when treatment restarts.
- Doubling doses: Taking extra doses to accelerate weight loss raises the risk of significant adverse effects.
- Sharing pens: Using a pen intended for one person increases infection risk and removes clinical oversight.
How will misusing Mounjaro affect my treatment?
Misusing Mounjaro means the medicine is no longer being taken as instructed, which removes the safeguards built into its licensing and clinical guidance. Prescribing decisions and patient support are based on approved dosing schedules and deviating from this places responsibility for harm or injury entirely with the user. Misuse can also affect eligibility for ongoing treatment and clinical support from a prescriber. Following the licensed instructions protects your health, your results and your access to safe, supervised care.
Sources (tap to expand)